While EEGs are the standard of care for epileptic patients in high-income countries, low- and middle-income countries struggle with access to EEGs due to limitations in resources, manpower, and expertise. The Smartphone Brain Scanner-2 (SBS2) is a potential mobile solution to provide diagnosis, classification of seizure types, and appropriate selection of anti-epileptic drugs for people with suspected epilepsy in these settings.
Instead of setting up large stationary EEG facilities, medical personnel can now consider investing in a $300 USD 14-electrode EasyCap headset to be used wirelessly with the SBS2 app on a mobile device.
